You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antiangiogenic

Showing 1 - 25 of 554
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)

Completed
  • Pathologic Myopia
  • Intravitreal injection
  • Mykolaiv, Ukraine
  • +2 more
Jan 23, 2023

Port Wine Stain Trial (Topical Antiangiogenic, Pulsed Dye Laser)

Withdrawn
  • Port Wine Stain
  • Topical Antiangiogenic
  • Pulsed Dye Laser
  • (no location specified)
Oct 28, 2022

Non Small Cell Lung Cancer Recurrent Trial (Toripalimab, Anlotinib and Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer Recurrent
  • Toripalimab, Anlotinib and Chemotherapy
  • (no location specified)
Apr 24, 2023

Hepatocellular Carcinoma Trial in Guangzhou (digital subtraction angiography., FOLFOX (oxaliplatin , leucovorin , fluorouracil ,

Recruiting
  • Hepatocellular Carcinoma
  • digital subtraction angiography.
  • FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Feb 7, 2023

Triple-negative Breast Cancer Trial in Bengbu (Albumin-Bound Paclitaxel, Apatinib Mesylate, Bevacizumab)

Recruiting
  • Triple-negative Breast Cancer
  • Albumin-Bound Paclitaxel
  • +2 more
  • Bengbu, Anhui, China
    Department of Medical Oncology, First Affiliated Hospital of Ben
Mar 15, 2022

Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)

Recruiting
  • Pathologic Myopia
  • Intravitreal injection
  • Lutsk, Ukraine
  • +3 more
Mar 23, 2022

Colorectal Tumors Trial in Wuhan (Surufatinib)

Recruiting
  • Colorectal Neoplasms
  • Chohort 1: Surufatinib
  • +2 more
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Nov 5, 2022

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cetntre
Sep 25, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel),

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel)
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Sep 17, 2022

NSCLC, Minimal Residual Disease, Immunotherapy Trial in Shanghai (sintilimab combined with anlotinib, sintilimab monotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • sintilimab combined with anlotinib
  • sintilimab monotherapy
  • Shanghai, China
    Shanghai Chest Hospital
Jul 14, 2022

Angioid Streaks of Macula Trial in Mykolaiv, Odessa (Intravitreal injection)

Recruiting
  • Angioid Streaks of Macula
  • Intravitreal injection
  • Mykolaiv, Ukraine
  • +2 more
Feb 2, 2021

Chorioretinitis Trial in Mykolaiv, Odessa (Intravitreal injection, Fluorescent angiography, Visometry)

Unknown status
  • Chorioretinitis
  • Intravitreal injection
  • +6 more
  • Mykolaiv, Ukraine
  • +2 more
Feb 2, 2021

Ovarian Cancer Trial in Tai'an (Bevacizumab, chemo, Fluzoparib)

Recruiting
  • Ovarian Cancer
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Dec 24, 2021

Subretinal Haematoma Linked to AMD Trial in France (Surgery, Intravitreal injections of gas, injections of an antiangiogenic)

Completed
  • Subretinal Haematoma Linked to AMD
  • Surgery
  • +2 more
  • Besancon, France
  • +16 more
Feb 3, 2021

Soluble Mediators, Cytokines, and Circulating Angiogenic Factors

Active, not recruiting
  • Non-small Cell Lung Cancer
    • Elche, Alicante, Spain
    • +24 more
    Nov 8, 2022

    Stereotactic Radiosurgery Combination With Anlotinib for Limited

    Completed
    • Stereotactic Body Radiation Therapy
    • Beijing, Beijing, China
      Department of Radiation Oncology Cancer Center, Peking Universit
    May 31, 2021

    Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial run by the NCI (topotecan, pazopanib)

    Completed
    Has Results
    • Glioblastoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 3, 2020

    Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Hangzhou (drug, procedure, other)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Neoadjuvant Therapy
    • Hangzhou, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 10, 2020

    Advanced or Metastatic Pancreatic Adenocarcinoma Trial in Germany (everolimus)

    Completed
    • Advanced or Metastatic Pancreatic Adenocarcinoma
    • Halle, Germany
    • +4 more
    Dec 17, 2020

    Unspecified Adult Solid Tumor Trial in San Francisco (bevacizumab, cyclophosphamide, imatinib)

    Completed
    • Unspecified Adult Solid Tumor
    • bevacizumab
    • +2 more
    • San Francisco, California
      UCSF Helen Diller Family Comprehensive Cancer Center
    Jul 24, 2020

    Renal Cell Carcinoma Trial in Boston (Arterial Spin Labeling Magnetic Resonance Imaging)

    Completed
    • Renal Cell Carcinoma
    • Arterial Spin Labeling Magnetic Resonance Imaging
    • Boston, Massachusetts
    • +1 more
    Feb 24, 2020

    Vascular Dysfunction and Antiangiogenic Therapy

    Completed
    • Solid Tumor
    • +3 more
      • Angers, France
        University Hospital Angers
      Nov 5, 2019

      Cardiac Dysfunction and Remodeling in Patients With Preeclampsia

      Recruiting
      • Preeclampsia
      • +2 more
      • Ecocardiographyc ultrasound
      • Barcelona, Spain
        Hospital de la Santa Creu i Sant Pau
      Feb 11, 2020

      Solid Tumors Trial in Hospitalet de Llobregat, Fuenlabrada, Madrid (Dovitinib, Dovitinib + Paclitaxel)

      Terminated
      • Solid Tumors
      • Hospitalet de Llobregat, Barcelona, Spain
      • +2 more
      Apr 15, 2020

      Trabectedin + PLD in Treatment of Relapsed Ovarian Cancer

      Completed
      Has Results
      • Relapsed Ovarian Cancer
      • Aalst, Flandes, Belgium
      • +64 more
      Sep 30, 2021